We report on a patient who presented to ENT services with right side epistaxis, frontal lobe headache, right infraorbital pain and the feeling of having a stuffy nose. CT and MRI were performed and later a biopsy confirmed the presence of sinonasal plasmocytoma. The Head and Neck oncology committee recommended radiotherapy as the choice of treatment. At the present time the patient is being followed on scheduled medical visits.
INTRODUCTION
Multiple Myeloma (MM), Solitary Bone Plasmocytoma (SBP) and Extramedullary Plasmocytoma (EMP) are plasmatic cell tumors that can be grouped in one category. Only 30% of extramedullary plasmocytomas evolve into multiple myelomas, while most bone plasmocytomas do (Gross et al., 2004; Seoane et al., 2003) Schridde described the first extramedullary plasmocytoma in 1905 (Schridde, 1905) . Extramedullary plasmocytomas represent less than 1% of all head and neck neoplasms and 4% of all non-epithelial nasal tumors (Kanotra & Lateef, 2010) . Extramedullary plasmocytomas are usually confined to soft tissues without bone involvement (Mcafee et al., 2004) and are produced by monoclonal plasmatic cell proliferation. Occurrence can happen at any age, but the majority appear more frequently in the fifth and seventh decades (Jaswal et al., 2008; Megat Shiraz et al., 2008; Lomeo et al., 2007) . Extramedullary plasmocytoma affects more males than females and studies have reported 4:1 and 2:1 ratios.
Lesions are predominantly seen in the upper nasal and GI tract affecting the submucosal tissue of the nasal cavity and paranasal sinuses 43.8% of the time, nasopharynx 18.3%, oropharynx 17.8% and larynx 11.1% (Megat Shiraz et al.; Lomeo et al.; Alexiou et al., 1999) *** location. The most common symptom is the presence of a lump or a sessile or pedunculated soft tissue mass. These lesions are circumscribed or infiltrating in 80% of the cases. Nasal obstruction and pressure is present in 35% of the cases, epistaxis 35%, pain 20%, ocular proptosis and blurry vision 15%, rhinorrea 10%, regional lymphadenopathy 10%, facial nerve paralysis 5% with symptoms often lasting from 4 to 5 months (Miller et al., 1998) .
Diagnosis of Extramedullary Plasmocytoma is achieved from a biopsy of the lesion and from histologically and immunohistochemical analysis. It is based on the presence of plasmatic cells showing birefraction with Congo red stain and presenting cytologically as benign tracts however, immunohistochemical tests demonstrate its monoclonality pointing to its neoplastic nature (González et al., 2011) . Neoplastic cell usually produce a large chain of monoclonal immunoglobulin that can be detected in both blood and urine (Pinto et al., 2007) . Radiologic imaging is crucial in the evaluation and localization of the size of the lesion. Magnetic Resonance Imaging (MRI) helps to determine the extent of soft tissue involvement often showing up as hyperintense lesions in T1 relaxation and homogeneously enhancing after Gadolinium contrast administration (Waldro & Mitchell, 1988; Cakir et al., 2003) . In Computed Tomography (CT), plasmocytomas are seen as radiopaque lesions, with homogeneous contrast enhancement.
Due to the high radiosensitivity of the tumor the recommended standard treatment is Radiation therapy. Depending on the size of the tumor, the therapeutic dose ranges from 40 to 50 Gys, for 4 to 6 weeks. Surgery could be used as the primary treatment if the size and location are favorable. In some cases, a combination of surgery and radiotherapy could be used depending on the possibility of resecting the lesion (Liebross et al., 1999) . Surgery is the best choice in cases of recurrence, while chemotherapy is indicated only when there are multiple and refractory lesions or when recurrence cannot be treated surgically (Soutar et al., 2004) .
It has been reported that 22% of the cases that have been adequately treated for multiple extramedullary plasmocytoma in the superior gastro intestinal tract have resulted in a local recurrence (Kanotra & Lateef) . Survival rate has been reported to be 10 years for 70% of those afflicted with the disease (Knowling et al., 1983) . The best prognostic indicator for multiple extramedullary plasmocytoma is weather the lesion progresses into multiple myeloma. Progression into multiple myeloma occurs in 15% to 20% of the cases and this is often associated with a poor prognosis reducing the survival rate from 10 years to 20 months (Fu & Perzin, 1978; Shreif et al., 2001) The prognosis is even worse when there are multiple lesions present (Mochimatsu et al., 1993; Wanebo et al., 1966) .
CASE REPORT
We report on a 52-year-old male patient who presented to ENT services without a significant clinical history. However, he complained of having the following symptoms; right side epistaxis, frontal lobe headache, right infraorbital pain and the feeling of having a stuffy nose. CT and MRI were performed with the CT revealing a solid and expansive mass occupying the right nasal fossa and left maxillary sinus. The mass was associated with inflammatory changes and dense secretions emerging from the right maxillary sinus (Fig.  1) . The mass demonstrated a moderate enhancement after intravenous contrast was given (Fig. 2) . The mass revealed erosion of the cribriform plate producing dehiscence without a clear extension into the anterior cranial fossa. Destruction of the nasal conchae, medial orbital wall and right maxillary sinus can be seen (Fig. 3) .
MRI revealed an expansive process of low intensity in the right nasal fossa suggestive of high cellular activity (Figs. 4 and 5) , and heterogeneous enhancement after gadolinium intravenous injection suggestive of necrosis in the central area. Also, a Focal lesion with rounded contours in the left maxillary sinus was seen with moderate enhancement after contrast injection. Mucosal thickening in the right maxillary sinus and the appearance of secretions were seen in the central (Figs. 6 and 7) .
A biopsy was performed and the immunohystochemical analysis revealed positive results for CD 138 and Vimentine; negative results for Fig. 2 Image following contrast media injection shows poor to moderate enhancement of the region. S-100 and Synaptophysin. Ultimately the histopathology revealed "Maxillary and Nasal Plamocytoma" (Fig 8) A consultation with the Hematology service to rule out Multiple Myeloma was carried out and consequently The Head and Neck Cancer Committee recommended radiation therapy resulting in excellent results as seen in Figure 9 . Currently the patient is evaluated on a regular basis to assess his progress. 
CONCLUSION

RESUMEN:
Se reporta el caso de un paciente que se presentó en el servicio de Otorrinolaringología con epistaxis, cefalea del lóbulo frontal derecho, dolor infraorbitario derecho y la sensación de tener la nariz tapada. Se realizaron TC y RNM, y luego una biopsia confirmó la presencia de un plasmocitoma nasosinusal. El comité de oncología de cabeza y cuello recomendó radioterapia como tratamiento de elección. En la actualidad, el paciente está en siguimiento y control en las visitas médicas regulares.
PALABRAS CLAVE: tomografía computarizada, resonancia nuclear magnética, plasmocitoma, nasosinusal, extramedular, tumor.
